These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4053215)

  • 1. Limits of antifungal prophylaxis by ketoconazole in leukemic patients.
    Mazzoni A; Fiorentini C; Cevenini R; Nanetti A
    Chemioterapia; 1985 Aug; 4(4):299-302. PubMed ID: 4053215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ketoconazole and antifungal prevention in leukemia. Pharmacokinetic study].
    Mazzoni A; Fiorentini C; Luglio G
    G Ital Chemioter; 1984; 31(1-2):163-8. PubMed ID: 6088339
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ketoconazole in the prevention of mycotic complications during cytostatic treatment of leukemias and lymphomas].
    Krcová V; Krc I; Kubis M; Mlcochová E; Podivínská I
    Vnitr Lek; 1985 Jun; 31(6):567-71. PubMed ID: 4036023
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylaxis of mycotic infections in immunocompromised patients: a review of 27 reports and publications.
    Cauwenbergh G
    Drugs Exp Clin Res; 1986; 12(5):419-27. PubMed ID: 3522162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of ketoconazole in bone marrow transplanted patients.
    Vu Van H; Piens MA; Archimbaud E; Monier MF; Guyotat D; Mojon M; Fiere D
    Nouv Rev Fr Hematol (1978); 1983; 25(4):241-4. PubMed ID: 6312409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of fungal infections with ketoconazole in cancer patients receiving cytostatic therapy].
    König HJ; Georgiou A; Kraft P; Mayer U
    Mycoses; 1988 Jun; 31(6):324-9. PubMed ID: 3173422
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients.
    Jones PG; Kauffman CA; McAuliffe LS; Liepman MK; Bergman AG
    Arch Intern Med; 1984 Mar; 144(3):549-51. PubMed ID: 6322710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketoconazole prophylaxis in patients with solid tumours receiving aggressive immunosuppressive therapy. An open randomized comparison between 200 mg/d and 400 mg/d doses.
    Scrimgeour E; Anderson JD
    S Afr Med J; 1985 Jun; 67(26):1044-5. PubMed ID: 3892729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Present and future of antifungal prophylaxis in leukemic patients].
    Mazzoni A
    Ann Ist Super Sanita; 1987; 23(4):743-5. PubMed ID: 3452284
    [No Abstract]   [Full Text] [Related]  

  • 10. How to improve the design of trials of antifungal prophylaxis among neutropenic adults with acute leukemia.
    Menichetti F
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S181-4. PubMed ID: 15546115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
    Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of mycosis in granulocytopenic patients. A comparative study between nystatin and ketoconazole.
    Avilés A; Ambríz R; Escobedo J; Sinco A; Pizzuto J; Macotela E
    Arch Invest Med (Mex); 1984; 15(1):55-65. PubMed ID: 6089686
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
    Parente F; Ardizzone S; Cernuschi M; Antinori S; Esposito R; Moroni M; Lazzarin A; Bianchi Porro G
    Am J Gastroenterol; 1994 Mar; 89(3):416-20. PubMed ID: 8122656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection.
    Manfredi R; Mastroianni A; Coronado OV; Chiodo F
    Arch Intern Med; 1997 Jan; 157(1):64-9. PubMed ID: 8996042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.
    Pollock AV; Evans M
    J Hosp Infect; 1984 Sep; 5(3):340-1. PubMed ID: 6208258
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fungal infections in leukemic patients: our experience during 5 years].
    Torre MA; Escalante R; López Martín JC; de la Maya MD; Martínez Estéfano E; López Lacomba D; González Aza C
    Sangre (Barc); 1996 Oct; 41(5):395-7. PubMed ID: 9026926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients.
    Wadhwa NK; Suh H; Cabralda T
    Adv Perit Dial; 1996; 12():189-91. PubMed ID: 8865899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose ketoconazole therapy and adrenal and testicular function in humans.
    Pont A; Graybill JR; Craven PC; Galgiani JN; Dismukes WE; Reitz RE; Stevens DA
    Arch Intern Med; 1984 Nov; 144(11):2150-3. PubMed ID: 6093722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic candidiasis in cancer patients.
    Maksymiuk AW; Thongprasert S; Hopfer R; Luna M; Fainstein V; Bodey GP
    Am J Med; 1984 Oct; 77(4D):20-7. PubMed ID: 6093530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.